Parkwalk Advisors
Parkwalk Advisors is a London-based venture capital firm that focuses on UK technology companies with IP backing, primarily those spun out from UK universities. The firm invests across seed to growth stages, including late-stage rounds, and is stage-agnostic, aiming to support unlisted companies with freedom to operate. It concentrates on companies originating from university research, especially in Cambridge and across the UK, and targets sectors such as healthcare, energy, materials, technology, artificial intelligence, big data, life sciences, cleantech, medtech, quantum computing, and the apps ecosystem. Typical investments range from about £0.3 million to £10 million, with capital structures kept in a single share class, and the firm may provide equity or debt financings. Investments are generally planned over a three- to eight-year horizon.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Laser
Oxford Endovascular
Series A in 2024
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Opsydia
Venture Round in 2022
Opsydia Limited, established in 2017 and based in Begbroke, UK, specializes in manufacturing advanced laser marking technology. This technology enables the creation of permanent, invisible structures such as serial numbers, images, and cryptographic data within transparent materials like diamonds, glass, polymers, and plastics without altering their surface or integrity. Opsydia's innovative solution aims to disrupt various industries by enhancing security, traceability, and authenticity in transparent materials.
Oxford Endovascular
Series B in 2021
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Oxford Endovascular
Series A in 2021
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Opsydia
Seed Round in 2018
Opsydia Limited, established in 2017 and based in Begbroke, UK, specializes in manufacturing advanced laser marking technology. This technology enables the creation of permanent, invisible structures such as serial numbers, images, and cryptographic data within transparent materials like diamonds, glass, polymers, and plastics without altering their surface or integrity. Opsydia's innovative solution aims to disrupt various industries by enhancing security, traceability, and authenticity in transparent materials.
Oxford Endovascular
Venture Round in 2018
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Oxford Endovascular
Series A in 2015
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Reduse
Series A in 2015
Reduse Limited is a company based in Cambridge, United Kingdom, that specializes in providing print removal services from paper using laser technology. Founded in 2015 by David Leal-Ayala, Hidde-Jan Lemstra, and Stuart Evans, Reduse aims to offer innovative solutions for the efficient recycling and repurposing of printed materials. The company focuses on sustainability by enabling the reuse of paper, thereby contributing to environmental conservation efforts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.